Nuveen’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.8M | Buy |
439,120
+200,681
| +84% | +$8.42M | 0.01% | 1100 |
|
|
2026
Q1 | $7.68M | Sell |
238,439
-343,835
| -59% | -$12.7M | ﹤0.01% | 1704 |
|
|
2025
Q4 | $24.5M | Sell |
582,274
-139,275
| -19% | -$5.61M | 0.01% | 1024 |
|
|
2025
Q3 | $24.8M | Sell |
721,549
-108,049
| -13% | -$3.1M | 0.01% | 1018 |
|
|
2025
Q2 | $22.4M | Sell |
829,598
-283,474
| -25% | -$8.21M | 0.01% | 1027 |
|
|
2025
Q1 | $33M | Sell |
1,113,072
-81,320
| -7% | -$3.1M | 0.01% | 821 |
|
|
2024
Q4 | $47.3M | Buy |
1,194,392
+8,797
| +0.7% | +$333K | 0.01% | 674 |
|
|
2024
Q3 | $40.4M | Buy |
1,185,595
+472,901
| +66% | +$13.3M | 0.01% | 763 |
|
|
2024
Q2 | $15.4M | Sell |
712,694
-314,733
| -31% | -$6.62M | ﹤0.01% | 1304 |
|
|
2024
Q1 | $22.8M | Buy |
1,027,427
+5,148
| +0.5% | +$126K | 0.01% | 1107 |
|
|
2023
Q4 | $28.1M | Sell |
1,022,279
-75,003
| -7% | -$1.81M | 0.01% | 928 |
|
|
2023
Q3 | $24.5M | Buy |
1,097,282
+165,505
| +18% | +$4.26M | 0.01% | 930 |
|
|
2023
Q2 | $23.7M | Buy |
931,777
+697
| +0.1% | +$16.9K | 0.01% | 972 |
|
|
2023
Q1 | $20.8M | Buy |
931,080
+651,413
| +233% | +$15.7M | 0.01% | 1023 |
|
|
2022
Q4 | $6.64M | Buy |
279,667
+14,971
| +6% | +$348K | ﹤0.01% | 1753 |
|
|
2022
Q3 | $4.39M | Sell |
264,696
-5,245
| -2% | -$118K | ﹤0.01% | 1977 |
|
|
2022
Q2 | $5.37M | Buy |
269,941
+1,047
| +0.4% | +$21.2K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $7.32M | Sell |
268,894
-5,111
| -2% | -$146K | ﹤0.01% | 1839 |
|
|
2021
Q4 | $11M | Sell |
274,005
-206,343
| -43% | -$9.12M | ﹤0.01% | 1631 |
|
|
2021
Q3 | $24.6M | Buy |
480,348
+45,214
| +10% | +$1.97M | 0.01% | 1127 |
|
|
2021
Q2 | $17.4M | Sell |
435,134
-41,068
| -9% | -$1.76M | 0.01% | 1481 |
|
|
2021
Q1 | $25.6M | Sell |
476,202
-51,943
| -10% | -$2.99M | 0.01% | 1138 |
|
|
2020
Q4 | $25.8M | Sell |
528,145
-3,227
| -0.6% | -$150K | 0.01% | 1081 |
|
|
2020
Q3 | $17.3M | Buy |
531,372
+183,168
| +53% | +$5.82M | 0.01% | 1151 |
|
|
2020
Q2 | $9.02M | Sell |
348,204
-81,789
| -19% | -$2.04M | ﹤0.01% | 1546 |
|
|
2020
Q1 | $10.5M | Sell |
429,993
-121,412
| -22% | -$3.06M | 0.01% | 1263 |
|
|
2019
Q4 | $15.4M | Sell |
551,405
-572,661
| -51% | -$14.8M | 0.01% | 1325 |
|
|
2019
Q3 | $27M | Sell |
1,124,066
-51,131
| -4% | -$1.36M | 0.01% | 971 |
|
|
2019
Q2 | $33.5M | Buy |
+1,175,197
| New | +$29.4M | 0.01% | 882 |
|
Other funds holding VCYT
Nuveen's VCYT Position: Q2 2026 in Review
Nuveen increased its Veracyte (VCYT) stake by 84% in Q2 2026, buying an estimated $8.42M and bringing the position to 439,120 shares worth $25.8M. The position accounts for 0.01% of the portfolio, ranked #1100.
Nuveen first reported a position in VCYT in Q2 2019 and has held it in 29 quarters since. The position peaked at $47.3M in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Nuveen held 439,120 shares of Veracyte worth $25.8M as of Q2 2026.
- Nuveen bought 200,681 Veracyte shares in Q2 2026, an estimated $8.42M.
- Veracyte made up 0.01% of Nuveen's portfolio in Q2 2026, its #1100 holding.
- Nuveen first reported a position in Veracyte in Q2 2019 and has held it in 29 quarters since.
- Nuveen's Veracyte position peaked at $47.3M in Q4 2024.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.